Recruitment.
Between 24 December 2020 and 27 July 2021, 48 individuals were assessed for eligibility; a total of 28 individuals met the study eligibility criteria and were randomized, with 27 of these 28 (96.4%) being administered either COVID-HIGIV (Disposition flow chart of participants for study EBS-CVH-003.